3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Polycythemia Vera
6
Thrombocythemia, Essential
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Myeloproliferative Disorders
2
Melanoma
2
Solid Cancers
1
Skin Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Neoplasms
1
Neoplasm of Uncertain Malignant Potential
1
Neoplasm Metastasis
1
Leukemia, Myeloid, Acute
1
Hepatitis C, Chronic
1
Glioma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Blast Crisis
1
Interventions
Cyclophosphamide
45
Peripheral Blood Stem Cell Transplantation
44
fludarabine phosphate
40
Busulfan
32
Tacrolimus
27
Filgrastim
26
Methotrexate
24
Cytarabine
24
Cyclosporine
23
Antilymphocyte Serum
22
Radiotherapy
20
Mycophenolic Acid
19
Whole-Body Irradiation
18
Etoposide
18
Imatinib Mesylate
17
Methylprednisolone
15
Melphalan
13
Cord Blood Stem Cell Transplantation
10
sargramostim
9
Thiotepa
9
fludarabine
8
Psychiatric Rehabilitation
8
Dasatinib
8
Topotecan
7
Therapeutics
7
Prednisone
7
Flow Cytometry
7
Carboplatin
7
merphos
6
Decitabine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Blast Crisis
×
peginterferon alfa-2a
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled